41
Miltefosine and GM-CSF in Cutaneous Leishmaniasis
Condition(s):Cutaneous LeishmaniasisLast Updated:April 7, 2020Completed
Leishmaniasis: 192 Clinical Trials, Page 5 of 20
Hide Studies Not Open or Pending
42
The Association of Miltefosine and Pentoxifylline to Treat Mucosal and Cutaneous Leishmaniasis: A Clinical Trial in Brazil
Condition(s):LeishmaniasisLast Updated:May 27, 2022Active, not recruiting
43
Mediterranean Visceral Leishmaniasis With Leishmania Infantum
Condition(s):LeishmaniasisLast Updated:October 19, 2020Unknown status
44
To Study the Effect Of Single Infusions Of Amphotericin B Lipid Preparations in Treatment of Patients Of Kala Azar
Condition(s):Leishmaniasis, VisceralLast Updated:June 2, 2011Completed
45
Evaluation to Assess the Usability of rK28 for the Diagnosis of Visceral Leishmaniasis in Kenya
Condition(s):Visceral LeishmaniasisLast Updated:April 7, 2023Recruiting
46
High Dose Fluconazole in Cutaneous Leishmaniasis in Bahia and Manaus
Condition(s):Cutaneous LeishmaniasisLast Updated:December 2, 2015Terminated
47
Treatment of Cutaneous Leishmaniasis With Meglumine Antimoniate Versus Meglumine Antimoniate and Allopurinol
Condition(s):Leishmaniasis, CutaneousLast Updated:June 2, 2010Completed
48
Study of the Efficacy of Daylight Activated Photodynamic Therapy in the Treatment of Cutaneous Leishmaniasis
Condition(s):Cutaneous LeishmaniasisLast Updated:August 16, 2011Unknown status
49
WR 279,396 for the Treatment of Cutaneous Leishmaniasis
Condition(s):Cutaneous LeishmaniasisLast Updated:January 25, 2017Completed
50
SCH708980 With and Without AmBisome for Visceral Leishmaniasis
Condition(s):Leishmaniasis; Effects of ImmunotherapyLast Updated:August 28, 2013Withdrawn